$FRMI

Today’s top U.S. stock movers: Fermi, NIQ and others surge on AI and biotech catalysts

Investing.com reports major U.S. stock movers, led by FRMI up 22.2% on an AI campus lease and potential revenue expansion, ALMR up 28.3% after launching an immune profiling panel, and Hertz up 24.5% on index removal and heavy options activity. Other gainers include Septerna, Rapid7, Kopin, and NextNav, with catalysts tied to AI, biotech, and earnings.

Original reporting
Published Aug 11, 2026, 6:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 6:37 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMarket movers
Primary signal
$FRMI
Bullish
low confidence
Mentioned
$FRMI · $ALMR · $KOPN · $RPD · $NN · $COMP
Relevance
4/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$FRMIBullishLow
01

Why it matters

The only actionable edge is identifying which tickers are tied to same-day company-specific catalysts versus flow-driven moves; however, the scrape lacks verification details for several claims.

02

Market read

This is a catalyst-driven mover list rather than a single-company fundamental update; it is most useful for short-term momentum and volatility management.

03

What to watch

The scrape does not provide primary sources (filings, contract terms, trial endpoints, or guidance numbers) for several catalysts, so traders should verify before sizing.

Relevance 4/10Novelty 3/10Timing: today’s intraday U.S. stock-mover snapshot

Background

The article is a daily U.S. market wrap focused on top gainers, attributing moves to AI, energy, biotech catalysts, and some speculation-driven trading.

Company-level read

Ticker impact

$FRMIBullishLow confidence
Context

FRMI is cited as up 22.2% on an alleged $6.5B AI campus lease that could expand contracted revenue.

Expected impact

Near-term upside bias with elevated volatility; follow-through depends on lease confirmation and expansion terms.

Evidence & confidence

The article attributes the move to a large AI lease and frames potential revenue expansion, but provides no primary filing, contract terms, or verification.

$ALMRBullishMedium confidence
Context

ALMR is listed as up 28.3% after launching a new immune profiling panel expanding its biotech offering.

Expected impact

Likely continued strength if investors treat the panel as incremental revenue and adoption accelerates.

Evidence & confidence

The text links the gain to a specific product launch, which is a concrete company-specific catalyst even without financial figures.

$KOPNNeutralLow confidence
Context

Kopin (KOPN) is up 21.1% and the article says insider activity is reported, fueling speculative action.

Expected impact

Short-term volatility likely persists; conviction depends on the nature and size of the insider transaction.

Evidence & confidence

The scrape mentions insider activity but does not specify transaction type, size, or filing source, limiting signal quality.

$RPDNeutralMedium confidence
Context

Rapid7 (RPD) is up 18.7% after an earnings beat with a neutral outlook mentioned in the article.

Expected impact

Moderate upside bias initially, with risk of pullback if investors focus on the neutral outlook.

Evidence & confidence

The text provides a clear earnings-beat catalyst and notes outlook neutrality, which is actionable for near-term positioning.

$NNNeutralLow confidence
Context

NextNav (NN) is up 16.7% and the article attributes the move to location-tech news with modest guidance.

Expected impact

Choppy trading; upside continuation possible but likely capped without stronger guidance.

Evidence & confidence

The scrape does not provide the specific guidance numbers or the exact news item beyond broad framing.

$COMPNeutralLow confidence
Context

Compass Diversified (COMP) is up 12.4% and the article frames it as a dividend play and value rebound.

Expected impact

Limited upside unless there is a fresh capital return or earnings catalyst not included in the scrape.

Evidence & confidence

The catalyst is narrative-based (dividend play, value rebound) with no concrete new corporate action described.

Market effects

AI and biotech names are highlighted as leading movers, reinforcing a near-term risk-on rotation into catalyst-driven small and mid caps.

Primarily U.S.-centric flow story; no direct cross-market transmission details provided beyond general volatility.

No explicit global macro or international policy linkage beyond a brief mention of Hormuz reopening jitters.

Counterpoint

Some of the biggest movers appear driven by positioning (index removal, options activity) or vague “insider activity” rather than verifiable fundamentals, increasing mean-reversion risk.

Key entities

  • Fermi Inc.

    Named as the top mover, up 22.2% on an alleged $6.5B AI campus lease and potential revenue expansion.

  • ALMR

    Named as a biotech product-launch winner, up 28.3% on a new immune profiling panel.

  • Hertz Global Holdings, Inc.

    Named as a high-volatility mover, up 24.5% on index removal and options activity.

  • Rapid7 Inc

    Named as an earnings-beat winner, up 18.7% with neutral outlook mentioned.

Related articles

$COMPMed

Tribeca tenants blame $5K rents on nation's largest brokerage in new federal complaint

A federal class-action lawsuit accuses Compass, the nation's largest real estate brokerage, of monopolizing 80% of Manhattan rentals and inflating prices by hiding listings. Tenants claim they pay $5,270/month for one-bedroom apartments due to Compass' actions. Compass faces multiple investigations and lawsuits over market practices. Manhattan's median rent hit a record $5,000 last month, with only 1.4% of apartments available.

$FRMIHighAI 9/10

A Landmark Power Deal Puts Fermi’s (FRMI) Big Bet to the Test

Fermi Inc. (FRMI) announced a binding agreement with TensorWave for up to 650 MW of power, with Phase 1 valued at $6.5B. The company also secured hardware and financing, including a $382M convertible note offering. However, revenue depends on future expansions and financing, with delivery targets set for 2027-2029.

$COMPMedAI 8/10

Compass is executing, agents still need a seller

Compass reported strong Q2 earnings with $4.3B revenue and $92M net income, exceeding expectations. CEO Robert Reffkin criticized MLS rules, arguing they stifle competition. The company guided Q3 revenue between $3.85B and $4.05B. Regulatory scrutiny includes a House subcommittee inquiry and a NY AG review. Reffkin's strategy aims to route buyers to Compass listings, but its impact on sellers is debated.

$FRMIHighAI 9/10

Fermi (FRMI) Q2 2026 Earnings Call Transcript

Fermi Inc. (FRMI) reported Q2 2026 earnings, highlighting $6.5B in anchor customer revenue, a $431M convertible notes offering, and a 2.6GW power alliance. The company reported a net loss of $25.8M and $91.7M in cash. Key projects include the 4.8GW Project Matador campus, with power delivery targets set for 2027. Management emphasized strategic milestones and risk mitigation.

$RPDHighAI 8/10

Rapid7 (RPD) Bets On A Sharper Focus To Reverse Its Slide

Rapid7 (RPD) reported Q2 earnings with a 1% YoY ARR growth to $824M, driven by 5% YoY growth in detection and response. Profitability beat guidance with non-GAAP operating income of $28.9M. The company cut 12% of its workforce to improve margins. However, total ARR and revenue declined, with Q3 ARR guided down to $812M. Management raised full-year non-GAAP operating income guidance to $129M-$133M. The stock trades at a forward P/E of 6.88.

$NNMed

NextNav (NN) Q2 2026 Earnings Call Transcript

NextNav reported Q2 2026 revenue of $1.15M, down from $1.20M a year prior, and a net loss of $33.76M, primarily due to noncash losses. The company converted $190M in convertible debt to common stock and redeemed public warrants, ending with $298M in liquidity. NextNav highlighted partnerships and progress in 3D PNT technology, including a SpaceX filing supporting its spectrum proposal and timing accuracy of 20 nanoseconds.